on 06 Feb 2024
Last Applicant/ Owned by
Naka-ku, Nagoya-shi, Aichi-ken 460-8625
JP
Serial Number
79370102 filed on 17th Feb 2023
Registration Number
7296358 registered on 06th Feb 2024
Correspondent Address
Erica Halstead
Erica Halstead Womble Bond Dickinson (US) LLP
950 Third Ave., Suite 2400
New York, NY 10022
UNITED STATES
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disea Read More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain
N/A
N/A
No 79370102
No Service/Collective Mark
No 115785.01330
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
17th Jun 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
13th May 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
13th May 2024 | FINAL DISPOSITION PROCESSED |
06th May 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
06th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
27th Nov 2023 | NOTIFICATION PROCESSED BY IB |
21st Nov 2023 | PUBLISHED FOR OPPOSITION |
21st Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
01st Nov 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |